|
|
<p>Since the start of the COVID-19 pandemic, the UK has championed the importance of rapid, equitable access to safe and effective vaccines. We are among the largest donors to the COVAX Advance Market Commitment (AMC), committing £548 million, which through match-funding leveraged $1 billion from other donors in 2020. This support to COVAX has been critical to it distributing COVID-19 vaccines to over 125 countries and economies, with the aim to provide up to 1.8 billion doses to low- and middle-income countries by early 2022. The UK has also committed to sharing 100 million vaccine doses by June 2022, with the majority going to COVAX.</p><p>The UK's investment in the research and development of the Oxford/AstraZeneca vaccine has been a key contribution to the global vaccination effort. So far, 450 million doses of the vaccine have been distributed worldwide at non-profit prices, with two-thirds going to lower- and middle- income countries.</p> |